Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v1-EN
Language English English
Date Updated 2023-03-25 2023-03-17
Drug Identification Number 02471469 02471469
Brand name OZEMPIC OZEMPIC
Common or Proper name Ozempic Ozempic
Company Name NOVO NORDISK CANADA INC NOVO NORDISK CANADA INC
Ingredients SEMAGLUTIDE SEMAGLUTIDE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 1
ATC code A10BJ A10BJ
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2023-03-17 2023-03-17
Actual start date 2023-03-17 2023-03-17
Estimated end date 2023-03-24 2023-03-24
Actual end date 2023-03-24
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Shortage due to short term supply - demand imbalance For any questions or concerns, please contact our Customer Care Team at 1-800-465-4334 (Monday-Friday, 9 AM to 5 PM Eastern Time, excluding holidays) Shortage due to short term supply - demand imbalance For any questions or concerns, please contact our Customer Care Team at 1-800-465-4334 (Monday-Friday, 9 AM to 5 PM Eastern Time, excluding holidays)
Health Canada comments